Citation: Gjcm. Kolvenbag et Bja. Furr, BICALUTAMIDE (CASODEX) DEVELOPMENT - FROM THEORY TO THERAPY, The cancer journal from Scientific American, 3(4), 1997, pp. 192-203
Citation: Grp. Blackledge et al., CASODEX(TM) (BICALUTAMIDE) - OVERVIEW OF A NEW ANTIANDROGEN DEVELOPEDFOR THE TREATMENT OF PROSTATE-CANCER, European urology, 31, 1997, pp. 30-39
Citation: Bja. Furr et H. Tucker, THE PRECLINICAL DEVELOPMENT OF BICALUTAMIDE - PHARMACODYNAMICS AND MECHANISM OF ACTION, Urology, 47(1A), 1996, pp. 13-25
Authors:
BAISHYA N
COOPER MJ
HART IC
JACKSON PS
FURR BJA
JENKIN G
POPE GS
Citation: N. Baishya et al., EFFECTS OF LUTEOLYTIC DOSES OF PROSTAGLANDIN-F2-ALPHA AND CLOPROSTENOL ON CONCENTRATIONS OF PROGESTERONE, LUTEINIZING-HORMONE, FOLLICLE-STIMULATING-HORMONE, GLUCOSE, INSULIN, GROWTH-HORMONE, THYROXINE, PROLACTIN AND CORTISOL IN JUGULAR PLASMA OF LACTATING DAIRY-COWS, British Veterinary Journal, 150(6), 1994, pp. 569-583